SUBSEQUENT EVENTS (Details) - Subsequent Event [Member] - Amerigen Pharmaceuticals, Ltd. $ in Millions	Jan. 08, 2020 USD ($) item
SUBSEQUENT EVENTS
Number Of Generic Drug Products Acquired | item	23
Finite-lived intangible assets acquired	$ 52.5
Amount of contingent profit share payments	$ 25.0
Number of years contingent profit share payable	4 years
Payments to acquire intangible assets	$ 4.0